Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ:323990)
4,825.00
-115.00 (-2.33%)
Jun 10, 2026, 3:30 PM KST
-51.16% (1Y)
| Market Cap | 112.22B -48.2% |
| Revenue (ttm) | n/a +13,737.3% |
| Net Income | n/a |
| EPS | n/a |
| Shares Out | 23.26M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 77,092 |
| Open | 5,100.00 |
| Previous Close | 4,940.00 |
| Day's Range | 4,700.00 - 5,190.00 |
| 52-Week Range | 4,700.00 - 11,520.00 |
| Beta | 0.66 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |